#RLYB
🚨 JUST IN: $RLYB
Rallybio expects Avenzo merger to close Nov 20; sets $13.90/share cash distribution

#SEC #stocks #investing #RLYB #Mergers
🔗 secwatch.observer
November 12, 2026 at 9:58 PM
SELL $RLYB (RLYB.O) [StockSplit] Reverse Stock Split; Announced @ 13:15:03Z
November 11, 2026 at 1:15 PM
🚨 $RLYB
On November 10, 2026, Rallybio Corporation announced that it will effect a one-for-two reverse stock split of its issued and outstanding common stock in connection with the transactions contemplated by the Agreement and Plan of Merger and Reorganization , dated as of May 31, 2026, among t...
SEC Filing: RLYB
Click to view the official SEC document.
www.sec.gov
November 10, 2026 at 10:21 PM
Rallybio Announces Reverse Stock Split of Common Stock in Connection with the Proposed Merger with Avenzo
Rallybio (Nasdaq: RLYB) will implement a one-for-two reverse stock split, expected to take effect November 20, 2026, before its anticipated Avenzo merger.The split is expected to become effective at 12:01 a.m. Eastern Time, combining every two outstanding common shares into one. Outstanding shares will fall from approximately 5.6 million to 2.8 million, before the merger closes. The authorized common share count will not change. Stockholders approved a ratio range of one-for-two to one-for-nine on November 4; the board approved one-for-two on November 8 with Avenzo’s agreement.After applicable Nasdaq approvals and the merger closing, Rallybio plans to become Avenzo Therapeutics and trade on the Nasdaq Capital Market as AVZO. Proportionate adjustments will apply to outstanding pre-funded warrants, equity awards and shares reserved under equity incentive plans.
www.stocktitan.net
November 10, 2026 at 10:15 PM
Trading Halted for $RLYB Rallybio Corp Cmn Stk | at 17:44:05.880 ET on NASDAQ | Halt - News Pending | 2026-11-06
November 6, 2026 at 10:48 PM
🚨 $RLYB
Rallybio Corporation previously disclosed that, subject to the satisfaction or waiver of any outstanding closing conditions, the Company anticipated the transactions contemplated by the Agreement and Plan of Merger and Reorganization, dated as of May 31, 2026 , by and among the Company, A...
SEC Filing: RLYB
Click to view the official SEC document.
www.sec.gov
November 6, 2026 at 10:27 PM
🚨 $RLYB
HUNT RONALD (Insider) reported special transactions (Non-P/S).
SEC Filing: RLYB
Click to view the official SEC document.
www.sec.gov
November 5, 2026 at 10:15 PM
🚨 $RLYB
MACKAY MARTIN (Insider) reported special transactions (Non-P/S).
SEC Filing: RLYB
Click to view the official SEC document.
www.sec.gov
November 5, 2026 at 10:15 PM
🚨 JUST IN: $RLYB
Rallybio holders approve Avenzo merger and $13.90/share cash distribution; close expected Nov. 6

#SEC #stocks #investing #RLYB #Mergers
🔗 secwatch.observer
November 4, 2026 at 10:11 PM
I looked at the business behind $RLYB (Rallybio Corp) for you. Based on financial data and reported results.

At what market price would buying or selling $RLYB make sense to you?

#RLYB #Rallybio
November 4, 2026 at 8:09 PM
🚨 $RLYB
As previously disclosed, on October 25, 2026, the Company’s board of directors declared a special cash distribution to its stockholders in connection with the Merger . The Company has determined that the aggregate amount of the Cash Distribution is $83.6 million, or $13.90 per share.
SEC Filing: RLYB
Click to view the official SEC document.
www.sec.gov
November 4, 2026 at 10:38 PM
Biotech catalysts today (Wed Nov 4)
9:30 AM ET: $WVE investor event
$RLYB conference presentation
$VKTX conference call (VK2735)
Dates from the companies' SEC filings
#Biotech #Stocks

Visit for more info: www.elixstocks.com
Educational only. Not investment advice.
Biotech catalysts today — ElixStocks
9:30 AM ET: $WVE investor event; $RLYB conference presentation; $VKTX conference call (VK2735)
elixstocks.com
November 4, 2026 at 12:15 PM
🚨 $RLYB
Lieber Jonathan I (Chief Financial Officer) reported special transactions (Non-P/S).
SEC Filing: RLYB
Click to view the official SEC document.
www.sec.gov
November 2, 2026 at 10:30 PM
🚨 $RLYB
HUNT RONALD (Insider) reported special transactions (Non-P/S).
SEC Filing: RLYB
Click to view the official SEC document.
www.sec.gov
November 2, 2026 at 10:27 PM
🚨 $RLYB
Nash Christine A (Insider) reported special transactions (Non-P/S).
SEC Filing: RLYB
Click to view the official SEC document.
www.sec.gov
October 30, 2026 at 10:07 PM
🚨 $RLYB
Uden Stephen (Chief Executive Officer) reported special transactions (Non-P/S).
SEC Filing: RLYB
Click to view the official SEC document.
www.sec.gov
October 29, 2026 at 9:20 PM
🚨 $RLYB
Chung Wendy (Insider) reported special transactions (Non-P/S).
SEC Filing: RLYB
Click to view the official SEC document.
www.sec.gov
October 28, 2026 at 9:04 PM
🚨 $RLYB
Lieber Jonathan I (Chief Financial Officer) sold 599 shares at an average price of $16.0400 per common share. (Date: 2026-10-27)
SEC Filing: RLYB
Click to view the official SEC document.
www.sec.gov
October 28, 2026 at 9:04 PM
🚨 $RLYB
As previously disclosed, on May 31, 2026, the Rallybio Corporation, a Delaware corporation , entered into an Agreement and Plan of Merger and Reorganization with Avenzo Therapeutics, Inc., a Delaware corporation , and Farmington Merger Sub, Inc., a Delaware corporation and wholly-owned su...
SEC Filing: RLYB
Click to view the official SEC document.
www.sec.gov
October 26, 2026 at 8:53 PM
🚨 $RLYB
Boudreau Helen M (Insider) reported special transactions (Non-P/S).
SEC Filing: RLYB
Click to view the official SEC document.
www.sec.gov
October 20, 2026 at 9:29 PM
🚨 $RLYB
Soteropoulos Paula (Insider) reported special transactions (Non-P/S).
SEC Filing: RLYB
Click to view the official SEC document.
www.sec.gov
October 20, 2026 at 9:32 PM
🚨 $RLYB
Hopfner Robert Lorne (Insider) reported special transactions (Non-P/S).
SEC Filing: RLYB
Click to view the official SEC document.
www.sec.gov
October 14, 2026 at 8:35 PM
🚨 $RLYB
Lieber Jonathan I (Chief Financial Officer) reported special transactions (Non-P/S).
SEC Filing: RLYB
Click to view the official SEC document.
www.sec.gov
October 13, 2026 at 8:51 PM
🚨 $RLYB
Uden Stephen (Chief Executive Officer) reported special transactions (Non-P/S).
SEC Filing: RLYB
Click to view the official SEC document.
www.sec.gov
October 8, 2026 at 9:05 PM
🚨 $RLYB
Lieber Jonathan I (Chief Financial Officer) reported special transactions (Non-P/S).
SEC Filing: RLYB
Click to view the official SEC document.
www.sec.gov
October 1, 2026 at 9:42 PM